LLY stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
LECHLEITER JOHN C2023/04/10President and COO155390-766662023-04-100000059478000005947878724
-
Ricks David A2023/04/09SVP and Pres, Lilly Bio-Meds170728-408462023-04-0900000594780000059478129882
-
LECHLEITER JOHN C2023/04/08President and COO155390-766662023-04-080000059478000005947878724
-
Hedley Mary Lynne2023/04/07512023-04-070000059478000005947851
-
Hedley Mary Lynne2023/04/06512023-04-060000059478000005947851
-
Zakrowski Donald A2023/04/05Chief Accounting Officer46594-272002023-04-050000059478000005947819394
-
Hedley Mary Lynne2023/04/04512023-04-040000059478000005947851
-
Hedley Mary Lynne2023/04/03512023-04-030000059478000005947851
-
Ricks David A2023/04/02SVP and Pres, Lilly Bio-Meds170728-408462023-04-0200000594780000059478129882
-
Ricks David A2023/04/01SVP and Pres, Lilly Bio-Meds170728-408462023-04-0100000594780000059478129882
Related News

ASML Stock Falls 14% Since February High—Can NASDAQ:ASML Reclaim Its Uptrend?
TradingNEWS Archive
28.04.25

Tesla (NASDAQ:TSLA) Advances to $295.50 on Full Self-Driving Gains and Production Efficiencies
TradingNEWS Archive
28.04.25

Pfizer Stock at $22.50—Could That 7.6% Yield and a $64 B Revenue Outlook Turn PFE Around?
TradingNEWS Archive
25.04.25